BridgeMD
New treatment option for Acute Coronary Syndromes
Official title Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea
ClinicalTrials.gov ID: NCT07268859
What this study is testing
- What it's testing
- This study will be conducted in the coronary intensive care unit of Dr. Siyami Ersek Chest, Heart and Vascular Surgery Training and Research Hospital.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Between the ages of 18 and 65,
- No severe hearing and vision problems,
- Can speak and understand Turkish,
- Easy to communicate with,
- First-time sufferer of acute coronary syndrome (ACS) for the first time,
You likely can't join if
- Having any problem that prevents you from communicating cognitively, emotionally and verbally,
- Obstructive sleep abnormalities,
- Have a disease that affects respiratory function (stage IV cancer, bronchial asthma, COVID-19, lung cancer, pulmonary edema, chronic obstructive...
- With metabolic abnormalities,
- Intubated after the procedure,
- Previously treated with ticagrelor,
See the full eligibility criteria
- Between the ages of 18 and 65,
- No severe hearing and vision problems,
- Can speak and understand Turkish,
- Easy to communicate with,
- First-time sufferer of acute coronary syndrome (ACS) for the first time,
- Decided to start ticagrelor therapy,
- Able to adapt to treatment,
- Individuals who volunteered to participate in the research.
- Having any problem that prevents you from communicating cognitively, emotionally and verbally,
- Obstructive sleep abnormalities,
- Have a disease that affects respiratory function (stage IV cancer, bronchial asthma, COVID-19, lung cancer, pulmonary edema, chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary embolism, pneumonia...
- With metabolic abnormalities,
- Intubated after the procedure,
- Previously treated with ticagrelor,
- Individuals who did not volunteer to participate in the study. Losses to follow up
- Individuals who wish to leave the study voluntarily.
- Saturation value below 95%,
- The one with the arrest,
- Who will not be able to fulfill the requirements of the work,
- Individuals with life-threatening conditions
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Avcılar, Turkey (Türkiye)
- Istanbul, Üsküdar, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Avcılar, Turkey (Türkiye); Istanbul, Üsküdar, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.